Company intelligence / Profile preview
Azaya Therapeutics
San Antonio, Texas, United Statesazayatherapeutics.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Other
01
Overview
Azaya developed two nanoparticle-based oncology drugs: * ATI-0918 – a generic liposomal formulation of doxorubicin hydrochloride shown to be bioequivalent to branded products Doxil®/Caelyx® in Europe. * ATI-1123 – a patented nanoparticle-stabilized liposomal formulation of docetaxel that showed positive safety results in Phase I trials involving patients with solid tumors who failed other therapies.
The company’s technology aims to improve safety and efficacy by reformulating existing chemotherapy drugs using their proprietary nanoparticle platforms. After acquisition by Cytori Therapeutics in early 2017, these programs were integrated into Cytori's pipeline with plans for further clinical development and commercialization[1][2][3][5][7][8].
- Therapeutic areas
- Oncology
- Modalities
- Nanoparticle therapeuticsLiposomal formulationsProtein Stabilized Liposomes (PSL™)Protein Stabilized Nanoparticles (PSN™)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Azaya Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Azaya Therapeutics.